Lubrano, E., & Spadaro, A. (2011). Certolizumab: efficacy and safety profile of a novel pegylatedTNF-alpha blocking agent. Acta Biomedica Atenei Parmensis, 82(1), 26-34. https://mattioli1885journals.com/index.php/actabiomedica/article/view/1362